Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid

Agents and Actions

Volumn 5, Issue 2, 1975, Pages 137-144

  Vargaftig, B B ^a   Chignard, M ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BUCLADESINE; CYCLIC AMP; ISOPRENALINE; PAPAVERINE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

AORTA; DRUG ANTAGONISM; INTERNAL MEDICINE; RABBIT AORTA CONTRACTING SUBSTANCE; SMOOTH MUSCLE CONTRACTION; THROMBOCYTE AGGREGATION;

ANIMAL; AORTA; ARACHIDONIC ACIDS; BUCLADESINE; CYCLIC AMP; HISTAMINE RELEASE; HUMAN; IN VITRO; MYOCARDIAL CONTRACTION; PAPAVERINE; PLATELET AGGREGATION; PROSTAGLANDINS; PROSTAGLANDINS E; PROSTAGLANDINS F; RABBITS; SRS-A; STIMULATION, CHEMICAL;

EID: 0016741234     PISSN: 00654299     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/BF02027355     Document Type: Article

References (37)

1. Modulation of Inflammation and Immunity by Cyclic AMP
2. Influence of Prostaglandins on Platelet Adhesiveness and Platelet Aggregation
3. Platelet Aggregation Induced by Arachidonic Acid is Accompanied by Release of Potential Inflammatory Mediators Distinct from PGE2 and PGF2a
4. The Synthesis of Prostaglandins in Human Platelets
5. Paradoxical Inhibition of the Effects of Bradykinin by some Sulfhydryl Reagents
6. The Release of Prostaglandins and Rabbit Aorta Contracting Substance (RCS) from Rabbit Spleen and its Antagonism by Anti-Inflammatory Drugs
7. Release of Vasoactive Substances from Guinea-Pig Lungs by Slow-Reacting Substance C and Arachidonic Acid
8. Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
9. Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-Like Drugs
10. Inhibition by Sulfhydryl Agents of Arachidonic Acid-Induced Platelet Aggregation and Release of Potential Inflammatory Substances
11. Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
12. The use of Isolated Organs for Detecting Active Substances in the Circulating Blood
13. Effect of Prostaglandin E2 and Aspirin on the Secondary Aggregation of Human Platelets
14. Cyclic 3′,5′-Adenosine Monophosphate in human Blood Platelets
15. Cyclic Phosphodiesterase Activity and the Action of Papaverine
16. Derivatives of Cyclic 3′,5′-adenosine Monophosphate
17. Effects of Collagen and of Aspirin on the Concentration of Guanosine 3′,5′-cyclic Monophosphate in Human Blood Platelets: Measurement by a Prelabelling Technique
18. Cyclic Nucleotides and Modulation of Effector Systems of Inflammation
19. Cyclic AMP Metabolism in Asthma: Studies with Leukocytes and Lymphocytes
20. Hormonal Control of Lysosomal Enzyme Release from Human Neutrophils
21. Histamine Release in vitro: Inhibition by Catecholamines and Methylxantines
22. Isolation and Structure of two Prostaglandin Endoperoxides that Structure of two Aggregation
23. An Endoperoxide Aggregator (Lass), Formed in Platelets in Response to Thrombotic Stimuli
24. Prostaglandin Endoperoxides IV. Effects on Smooth Muscle
25. The Generation from Arachidonic Acid of a Rabbit Aorta Contracting Substance (RCS) by a Microsomal Enzyme Preparation which also Generates Prostaglandins
26. Hydroperoxyde als Träger der darmerregenden Wirkung hochungesättigter Fettsäuren
27. Generation of Rabbit Aorta Contracting Substance in Blood by Slow Reacting Substance C and its Blockade by Non-Steroid Anti-Inflammatory Drugs
28. Inhibition by Non-Steroid Anti-Inflammatory Agents of Rabbit Aorta Contracting Activity Generated in Blood by Slow Reacting Substance C
29. Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins
30. The Effect of Sulfhydryl and Enzyme Inhibitors on Platelet Aggregation in vitro
31. Inhibition of Tumor Glycolysis by Hydrogen Peroxide Formed from Autoxidation of Unsaturated Fatty Acids
32. On the Mode of Action and Biochemical Properties of Anti-Inflammatory Drugs-I
33. Effects of Adrenaline on Human Blood Platelets
34. β-Adrenergic Receptors in Human Platelets
35. Propranolol as an Inhibitor of Platelet Aggregation: Membrane Action